Last updated: March 18, 2026
What is NDC 81284-0152?
NDC 81284-0152 refers to a specific drug product listed in the National Drug Code system. The detailed formulation, manufacturer, and indication can be confirmed via the FDA’s NDC database or commercial databases like IQVIA or FirstDatabank.
Product Overview
- Active Ingredient: The specific active compound, dosage, and form are obtained from the NDC record.
- Indication: Intended for the treatment of [disease/condition], pending FDA approval or existing market authorization.
- Manufacturer: Particulars are available from label or registration records.
- Market Status: Whether it’s a new entrant, generic, or branded.
Market Size Estimation
Current Market Landscape
- The drug market for similar therapeutics ranges between $X billion and $Y billion annually (source [1]).
- The specific therapy area has seen compound annual growth rates (CAGR) of Z% over the past five years (source [2]).
- Key competitors include [Competitor A], [Competitor B], and [Competitor C], holding market shares of X%, Y%, and Z%, respectively (source [3]).
Market Penetration Factors
- Regulatory approval status: Approved, pending, or under review.
- Reimbursement landscape: Coverage policies among Medicare, Medicaid, private insurers.
- Adoption rate: Estimated based on prescriber behavior, formulary inclusion, and clinical guidelines.
Price Projection Factors
Pricing Benchmarks
- Market entry price for similar drugs: $X per unit/authorization.
- Historically, branded drugs in the sector retail between $Y and $Z.
- For generics: prices tend to be 50-70% below brand levels ([4]).
Influencing Variables
- Regulatory Data: Any delays or accelerated approvals impact market entry timing.
- Manufacturing Costs: Trend impacts pricing, especially for biologics or complex generics.
- Competitive Landscape: New entrants suppress pricing; consolidation can increase prices.
- Reimbursement Policies: Payers’ cost-sharing influences net price.
- Pricing Regulations: Local and international pricing controls can limit or enable premiums.
Short-term Price Outlook (Next 1–2 Years)
- Initial price set at the average market entry level: approximately $X per dose.
- Anticipated discounts for hospital or formulary listings: 10–20%.
Long-term Price Trajectory (2–5 Years)
- With increased market penetration and volume, prices may decrease by 10-15%.
- If patent exclusivity persists and competition remains limited, prices could stabilize or even increase within negotiated caps.
Forecast Summary
| Year |
Estimated Market Share |
Estimated Price per Unit |
Revenue Projection |
| Year 1 |
5-10% of target market |
$X - $Y |
$A million |
| Year 3 |
20-30% of target market |
$X - $Y (adjusted for discounts) |
$B million |
| Year 5 |
40-50% of target market |
$X - $Y (stabilized) |
$C million |
Risks and Opportunities
Risks
- Regulatory delays could push launch timelines.
- Competitive pressure could erode market share and prices.
- Reimbursement hurdles may limit uptake.
Opportunities
- High unmet medical need can enable premium pricing.
- Strategic partnerships may unlock distribution advantages.
- Orphan drug status (if applicable) may provide pricing protections.
Key Takeaways
- The drug’s market size hinges on its approval status, indication, and competitive landscape.
- Pricing is expected between $X and $Y per unit initially, with potential declines as volume increases.
- Long-term profitability depends on market penetration, exclusivity, and payer acceptance.
FAQs
Q1. What factors primarily influence the drug’s price?
Regulatory approval, competition, manufacturing costs, reimbursement policies.
Q2. How does the market size impact price projections?
Larger markets can support higher prices initially, but saturation pressures lead to reductions over time.
Q3. When are price decreases typically observed?
Following patent expiration, increased competition, or reimbursement negotiations.
Q4. What is the typical launch price range for similar drugs?
Generally between $X and $Y, depending on the therapeutic area.
Q5. How can market dynamics affect pricing over the next five years?
Market entry of biosimilars or generics, payer negotiations, and evolving clinical guidelines influence pricing trajectories.
References
- IQVIA Institute. (2022). The Global Use of Medicines.
- Deloitte. (2021). Pharmaceutical Market Growth.
- FDA NDC Directory. (2023). Product details and approval status.
- First Databank. (2022). Pricing Trends for Therapeutics.
